This company listing is no longer active
This company may still be operating, however this listing is no longer active. Find out why through their latest events.
Resumen de acción 5D8
DEINOVE SA, a biotechnology company, discovers, develops, and produces compounds from microbials for the health, nutrition, and cosmetics industries worldwide.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 2/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
Competidores de Deinove SA
Historial de precios y rendimiento
| Historical stock prices | |
|---|---|
| Current Share Price | €0.018 |
| 52 Week High | €0.31 |
| 52 Week Low | €0.0001 |
| Beta | 0.78 |
| 1 Month Change | 0% |
| 3 Month Change | -11.59% |
| 1 Year Change | -93.51% |
| 3 Year Change | -97.48% |
| 5 Year Change | -99.50% |
| Change since IPO | -99.77% |
Noticias y actualizaciones recientes
Recent updates
Rentabilidad de los accionistas
| 5D8 | DE Chemicals | Mercado DE | |
|---|---|---|---|
| 7D | 0% | -1.5% | -1.5% |
| 1Y | -93.5% | -1.1% | 0.9% |
Rentabilidad vs. Industria: 5D8 underperformed the German Chemicals industry which returned -10.6% over the past year.
Rentabilidad vs. Mercado: 5D8 underperformed the German Market which returned -9% over the past year.
Volatilidad de los precios
| 5D8 volatility | |
|---|---|
| 5D8 Average Weekly Movement | n/a |
| Chemicals Industry Average Movement | 4.1% |
| Market Average Movement | 4.8% |
| 10% most volatile stocks in DE Market | 10.0% |
| 10% least volatile stocks in DE Market | 2.4% |
Precio estable de las acciones: 5D8's share price has been volatile over the past 3 months.
Volatilidad a lo largo del tiempo: Insufficient data to determine 5D8's volatility change over the past year.
Acerca de la empresa
| Fundada | Empleados | CEO | Página web |
|---|---|---|---|
| 2006 | 44 | Alexis Rideau | www.deinove.com |
Resumen de fundamentos de Deinove SA
| Estadísticas fundamentales de 5D8 | |
|---|---|
| Capitalización bursátil | €843.07k |
| Beneficios(TTM) | -€7.37m |
| Ingresos (TTM) | €241.00k |
3.5x
Ratio precio-ventas (PS)-0.1x
Ratio precio-beneficio (PE)¿Está 5D8 sobrevalorada?
Ver valor justo y análisis de valoraciónBeneficios e Ingresos
| Cuenta de resultados (TTM) de 5D8 | |
|---|---|
| Ingresos | €241.00k |
| Coste de los ingresos | €3.91m |
| Beneficio bruto | -€3.67m |
| Otros gastos | €3.71m |
| Beneficios | -€7.37m |
Últimos beneficios comunicados
Jun 30, 2022
Próxima fecha de beneficios
n/a
| Beneficios por acción (BPA) | -0.23 |
| Margen bruto | -1,521.58% |
| Margen de beneficio neto | -3,058.92% |
| Ratio deuda/patrimonio | -127.0% |
¿Cómo se ha desempeñado 5D8 a largo plazo?
Ver rendimiento histórico y comparativa